ID: ALA2041761

Max Phase: Preclinical

Molecular Formula: C11H20ClN

Molecular Weight: 165.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.NC12CCC3CC(CC(C3)C1)C2

Standard InChI:  InChI=1S/C11H19N.ClH/c12-11-2-1-8-3-9(6-11)5-10(4-8)7-11;/h8-10H,1-7,12H2;1H

Standard InChI Key:  QFXNEFBTIHXVEA-UHFFFAOYSA-N

Associated Targets(non-human)

Matrix protein 2 436 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 165.28Molecular Weight (Monoisotopic): 165.1517AlogP: 2.30#Rotatable Bonds: 0
Polar Surface Area: 26.02Molecular Species: BASEHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.72CX LogP: 1.91CX LogD: -0.94
Aromatic Rings: 0Heavy Atoms: 12QED Weighted: 0.59Np Likeness Score: 0.60

References

1. Wang J, Ma C, Balannik V, Pinto LH, Lamb RA, Degrado WF..  (2011)  Exploring the Requirements for the Hydrophobic Scaffold and Polar Amine in inhibitors of M2 from Influenza A Virus.,  (4): [PMID:21691418] [10.1021/ml100297w]

Source